SPOTLIGHT -
How New and Emerging Trends in CAR T-Cell Therapy Can Affect Your Patients
Read More
Dr. Westin on Treatment Challenges in Large Cell Lymphoma
Jason Westin, MD, MS, FACP, discusses challenges with treating patients with large cell lymphoma.
Dr. Westin on the Role of R-CHOP in DLBCL
Jason Westin, MD, MS, FACP, discusses the role of rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in diffuse large B-cell lymphoma.
Dr. Westin on Potential for Chemo-Free Treatment in Large Cell Lymphoma
Jason Westin, MD, MS, FACP, discusses the potential for a chemotherapy-free future in large cell lymphoma.
Sotorasib Provides Consistent Clinical Benefit Over Docetaxel in Key Co-Alteration Subgroups of KRAS G12C+ NSCLC
Dabrafenib and Trametinib Plus Navitoclax Meets CR End Point in BRAF V600–mutant Metastatic Melanoma
Epcoritamab Plus Rituximab/Lenalidomide Produces Responses in High-risk R/R Follicular Lymphoma
TTFields Plus SOC Improves OS in Metastatic NSCLC After Progression on Platinum-based Chemotherapy
